DHC (Diversified Healthcare Trust) YoY EBITDA Growth: 163.92% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHC Diversified Healthcare Trust DHC
52 GF Score
Price $8.38
GF Value $3.35
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Diversified Healthcare Trust YoY EBITDA Growth?

Diversified Healthcare Trust DHC 52 YoY EBITDA Growth is 163.92% as of Jun. 2026. GuruFocus rates DHC with a GF Score™ of 52/100 and a GF Value™ of $3.35 (Significantly Overvalued). The stock has 4 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Diversified Healthcare Trust's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 163.92%.

Diversified Healthcare Trust's EBITDA per Share for the three months ended in Jun. 2026 was $0.26.

Diversified Healthcare Trust YoY EBITDA Growth Related Terms

Diversified Healthcare Trust YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Diversified Healthcare Trust's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diversified Healthcare Trust YoY EBITDA Growth Chart

Diversified Healthcare Trust Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 108.99 -39.68 -52.59 -26.91 -2.57

Diversified Healthcare Trust Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.25 -282.11 59.75 -50.62 163.92
DHC
52GF Score
Diversified Healthcare Trust DHC
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diversified Healthcare Trust YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Diversified Healthcare Trust's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.606-0.622)/ | 0.622 |
=-2.57 %

Diversified Healthcare Trust's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.256-0.097)/ | 0.097 |
=163.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 163.92% mean?
Diversified Healthcare Trust (DHC) has a YoY EBITDA Growth of 163.92% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Diversified Healthcare Trust and its competitors.
Is Diversified Healthcare Trust's YoY EBITDA Growth too high?
Diversified Healthcare Trust's current YoY EBITDA Growth is 163.92%. Overall, Diversified Healthcare Trust has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diversified Healthcare Trust's YoY EBITDA Growth compare to LTC and MPT?
Diversified Healthcare Trust's YoY EBITDA Growth of 163.92% can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a REITs company?
A good YoY EBITDA Growth depends on the REITs industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Diversified Healthcare Trust and its competitors. Diversified Healthcare Trust's current YoY EBITDA Growth is 163.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diversified Healthcare Trust stock overvalued right now?
Based on GuruFocus' analysis, Diversified Healthcare Trust (DHC) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.35, compared to a current price of $8.38 — trading 150.1% above its estimated fair value. The current YoY EBITDA Growth is 163.92%. Diversified Healthcare Trust's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Diversified Healthcare Trust (DHC), the current YoY EBITDA Growth is 163.92% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diversified Healthcare Trust (DHC) Overvalued in 2026?

Based on GuruFocus' analysis, Diversified Healthcare Trust stock appears to be overvalued. The current stock price of $8.38 is trading 150.1% above its estimated GF Value™ of $3.35. GuruFocus considers Diversified Healthcare Trust to be Significantly Overvalued.

Key valuation signals for DHC:

  • YoY EBITDA Growth: 163.92%
  • GF Value™: $3.35 vs. price of $8.38 (150.1% above fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the DHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diversified Healthcare Trust Business Description

Industry Real EstateREITs
Other Exchanges SNF:Germany
Address 255 Washington Street, Suite 300, Two Newton Place, Newton, MA, USA, 02458-1634
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.
52GF Score

Get the complete analysis for DHC

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.38
Price
$3.35
GF Value